Hiroko Shigemi
Impact in
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- DNA Repair Mechanisms 2
- Cell death mechanisms and regulation 2
-
- Antifungal resistance and susceptibility 4
- Co-authors
- Takahiro Yamauchi (12 shared papers)Takanori Ueda (12 shared papers)Kenji Shigemi (2 shared papers)Ritsuko Katoh‐Semba (1 shared paper)Atsuo Nakayama (1 shared paper)Toshiyuki Kumagai (1 shared paper)Masako Tsuzuki (1 shared paper)Futoshi Yoshida (1 shared paper)
- Journals
- Blood (3 papers)BMC Cancer (3 papers)Cancer Science (2 papers)Mycopathologia (1 paper)Medicine (1 paper)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Hiroko Shigemi
29 papers receiving 348 citations
Peers
Comparison fields: 5 of 88
- Developmental Neuroscience 25
- Biological Psychiatry 12
- Hematology 44
- Cellular and Molecular Neuroscience 69
- Cognitive Neuroscience 69
Countries citing papers authored by Hiroko Shigemi
This map shows the geographic impact of Hiroko Shigemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Shigemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Shigemi more than expected).
Fields of papers citing papers by Hiroko Shigemi
This network shows the impact of papers produced by Hiroko Shigemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Shigemi. The network helps show where Hiroko Shigemi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Shigemi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 122 | |
| 2 | 2015 | 29 | |
| 3 | 2013 | 26 | |
| 4 | 2020 | 22 | |
| 5 | 1990 | 20 | |
| 6 | 2019 | 15 | |
| 7 | Gemtuzumab ozogamicin and olaparib exert synergistic cytotoxicity in CD33-positive HL-60 myeloid leukemia cells. | 2014 | 15 |
| 8 | 2014 | 12 | |
| 9 | 2014 | 12 | |
| 10 | Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro. | 2014 | 11 |
| 11 | 2013 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2017 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2011 | 2 |
About Hiroko Shigemi
Hiroko Shigemi is a scholar working on Molecular Biology, Infectious Diseases, Public Health, Environmental and Occupational Health, Hematology and Epidemiology, having authored 29 papers that have together received 355 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Antifungal resistance and susceptibility (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Fungal Infections and Studies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers), Cell death mechanisms and regulation (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Developmental Neuroscience (25 citations), Biological Psychiatry (12 citations), Hematology (44 citations), Cellular and Molecular Neuroscience (69 citations) and Cognitive Neuroscience (69 citations). Hiroko Shigemi has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Takahiro Yamauchi, Takanori Ueda, Kenji Shigemi, Ritsuko Katoh‐Semba, Atsuo Nakayama, Toshiyuki Kumagai, Masako Tsuzuki, Futoshi Yoshida, Noriko Miyazaki and Hiromichi Iwasaki. Their work appears in journals such as Blood, BMC Cancer, Cancer Science, Mycopathologia and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.